AtriCure, Inc.
ATRCNASDAQHealthcareMedical Instruments & Supplies
As of Oct 23, 2026 close
- Market cap
- $2.88B
- P/E (TTM)
- 273.10
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $25.36$61.70
- Volume (live)
- -
- Avg. volume (3M)
- 1.23M
AtriCure (ATRC) Stock Price & Financial Analysis
AtriCure Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $58.53 - $59.56 |
|---|---|
| 52-Week High | $61.70 |
| 52-Week Low | $25.36 |
| Open | $58.94 |
| Volume (last close) | 497.08K |
| Average Volume (3M) | 1.23M |
| Revenue (TTM) | 569.62M |
|---|---|
| Net Income (TTM) | 10.55M |
| Free Cash Flow (TTM) | 58.11M |
| EPS (TTM) | $0.22 |
| Profit Margin | 1.85% |
| Operating Margin | 2.44% |
| Return on Equity (ROE) | 2.04% |
| Debt to Equity | 0.12 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 2.88B |
|---|---|
| Shares Outstanding | 48.87M |
| P/E Ratio (TTM) | 273.10 |
| Price to Sales (P/S) | 5.06 |
| Price to Book (P/B) | 5.58 |
| EV/EBITDA | 76.83 |
| 50-Day MA | $53.11 |
|---|---|
| 200-Day MA | $37.26 |
| 1-Year Change | +58.60% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
AtriCure at a Glance
As of the Oct 23, 2026 close, AtriCure (ATRC) has a market capitalization of $2.88B. The stock trades at 273.1× trailing earnings and 5.1× sales. Over the trailing twelve months it earned $10.55M on revenue of $569.62M (a 1.9% profit margin) and generated $58.11M of free cash flow. Revenue grew 13.9% year over year.
As of its latest reported balance sheet, it holds $167.79M in cash and securities against $61.00M of debt, a net cash position of $106.79M.
AtriCure does not currently pay a dividend.
The share price is up 58.6% over the past year. At $58.97 (the Oct 23, 2026 close) it sits near the top of its 52-week range of $25.36 to $61.70, above its 200-day moving average of $37.26.
Based on 8 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $60.25, 2.2% above the Oct 23, 2026 close.
Frequently Asked Questions About AtriCure
What is the current stock price for ATRC?
As of the Oct 23, 2026 close, ATRC stock trades at $58.97. The 52-week range is $25.36–$61.70, with a day range of $58.53–$59.56.
What is the P/E ratio for ATRC?
As of the Oct 23, 2026 close, AtriCure's trailing twelve-month (TTM) P/E ratio is 273.1, meaning investors pay $273.1 for every $1 of annual earnings. AtriCure operates in the Healthcare sector.
Does ATRC pay dividends?
AtriCure does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.
What do analysts recommend for ATRC?
Based on ratings from 8 professional analysts over the last 90 days, the consensus for ATRC is Buy. The average 12-month price target is $60.25, a 2.2% upside from the Oct 23, 2026 close of $58.97.
What is the market cap of ATRC?
As of the Oct 23, 2026 close, AtriCure's market capitalization is $2.88B, classifying it as a mid-cap company. AtriCure operates in the Healthcare sector within the Medical Instruments & Supplies industry.